2003
DOI: 10.1097/01.ju.0000084623.65480.f8
|View full text |Cite
|
Sign up to set email alerts
|

Tamsulosin: Efficacy and Safety in Patients With Neurogenic Lower Urinary Tract Dysfunction Due to Suprasacral Spinal Cord Injury

Abstract: Long-term tamsulosin treatment (0.4 and 0.8 mg once daily) seems to be effective and well tolerated in patients with neurogenic lower urinary tract dysfunction. The results suggest that it improves bladder storage and emptying, and decreases symptoms of autonomic dysreflexia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
50
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 96 publications
(53 citation statements)
references
References 17 publications
3
50
0
Order By: Relevance
“…Tamsulosin has been used clinically for treatment of voiding dysfunction and improvement in lower urinary tract function and symptoms of autonomic dysreflexia shown in randomized controlled trials in SCI patients (Abrams et al, 2003). Blockade of ␣-1A-adrenergic receptors by Tamsulosin had no effect in normal rats but improved bladder function in OP-control rats and to a greater extent in NRP/GRP rats, presumably through its action on upregulated ␣-1 receptors.…”
Section: Lower Urinary Tract Functionmentioning
confidence: 99%
See 1 more Smart Citation
“…Tamsulosin has been used clinically for treatment of voiding dysfunction and improvement in lower urinary tract function and symptoms of autonomic dysreflexia shown in randomized controlled trials in SCI patients (Abrams et al, 2003). Blockade of ␣-1A-adrenergic receptors by Tamsulosin had no effect in normal rats but improved bladder function in OP-control rats and to a greater extent in NRP/GRP rats, presumably through its action on upregulated ␣-1 receptors.…”
Section: Lower Urinary Tract Functionmentioning
confidence: 99%
“…Postsynaptic targets of severed descending pathways, particularly monoaminergic pathways, may become more sensitive to transmitters because of receptor upregulation (Roudet et al, 1993;Kim et al, 1999; Y. Hayashi, S. Jacob, J.-M. Nothias, S. McBride, R. Olexa, K. Simansky, M. Murray, and J. S. Shumsky, unpublished observations). The noradrenergic system is implicated in regulation of micturition (Ishizuka et al, 1996;Yoshiyama et al, 2000), and administration of antagonists improve lower urinary tract function in SCI patients (Abrams et al, 2003). We therefore examined the effects of administration of Tamsulosin, an ␣-1A receptor antagonist, on urodynamics.…”
Section: Introductionmentioning
confidence: 99%
“…Tamsulosine (0.4 resp. 0.8 mg once daily) improves storage capacity and emptying of the bladder (class II evidence [107]). Antispastic agents: Baclofen has a positive effect in spastic or dyssynergic sphincter when given orally (class III evidence [108], class III evidence [109]).…”
Section: Bladder Symptomsmentioning
confidence: 99%
“…In multiple sclerosis and suprasacral SCI patients, tamsulosin has been shown to improve bladder storage and emptying and is well-tolerated up to the maximum daily dose of 0.8 mg [30,31]. No effective drugs exist to increase outlet resistance, although α-adrenergic agonists, estrogens, β-adrenergic agonists, and tricyclic antidepressants all have been assessed [1•].…”
Section: Pharmacotherapymentioning
confidence: 99%